Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2017, Article ID 3090273, 5 pages
https://doi.org/10.1155/2017/3090273
Case Report

Anticoagulation for the Pregnant Patient with a Mechanical Heart Valve, No Perfect Therapy: Review of Guidelines for Anticoagulation in the Pregnant Patient

1Department of Medicine, University of Florida College of Medicine Jacksonville, Jacksonville, FL, USA
2Department of Cardiology, University of Florida College of Medicine Jacksonville, Jacksonville, FL, USA

Correspondence should be addressed to Aaron Richardson; ude.lfu.xaj@nosdrahcir.noraa

Received 26 May 2017; Revised 18 September 2017; Accepted 25 October 2017; Published 22 November 2017

Academic Editor: Magnus Baumhäkel

Copyright © 2017 Aaron Richardson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. McGoon, V. Fuster, D. C. McGoon, C. W. Pumphrey, J. R. Pluth, and L. R. Elveback, “Aortic and mitral valve incompetence: long-term follow-up (10 to 19 years) of patients treated with the Starr-Edwards prosthesis,” Journal of the American College of Cardiology, vol. 3, no. 4, pp. 930–938, 1984. View at Publisher · View at Google Scholar · View at Scopus
  2. C. McLintock, “Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option,” Thrombosis Research, vol. 127, no. 3, pp. S56–S60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Aguilera and A. Agustí, “Anticoagulation of pregnant women with mechanical heart valves,” Medicina Clinica, vol. 121, no. 19, pp. 755-756, 2003. View at Publisher · View at Google Scholar
  4. J. Hirsh, V. Fuster, J. Ansell, and J. L. Halperin, “American Heart Association/American College of Cardiology foundation guide to warfarin therapy,” Circulation, vol. 107, no. 12, pp. 1692–1711, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. A. Nishimura, C. M. Otto, R. O. Bonow et al., “2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease,” Journal of the American College of Cardiology, vol. 135, no. 2, pp. 252–289, 2017. View at Publisher · View at Google Scholar
  6. J. M. Castellano, R. L. Narayan, P. Vaishnava, and V. Fuster, “Anticoagulation during pregnancy in patients with a prosthetic heart valve,” Nature Reviews Cardiology, vol. 9, no. 7, pp. 415–424, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. K. E. Economy and A. M. Valente, “Mechanical heart valves in pregnancy: a sticky business,” Circulation, vol. 132, no. 2, pp. 79–81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Vitale, M. De Feo, L. S. De Santo, A. Pollice, N. Tedesco, and M. Cotrufo, “Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves,” Journal of the American College of Cardiology, vol. 33, no. 6, pp. 1637–1641, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Xu, J. Fan, X. Luo et al., “Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis,” Canadian Journal of Cardiology, vol. 32, no. 10, pp. 1248.e1–1248.e9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. C. McLintock, “Thromboembolism in pregnancy: challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves,” Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 28, no. 4, pp. 519–536, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Soma-Pillay, Z. Nene, T. M. Mathivha, and A. P. Macdonald, “The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves,” Obstetric Medicine, vol. 4, no. 1, pp. 24–27, 2011. View at Publisher · View at Google Scholar
  12. Y. Yinon, S. C. Siu, C. Warshafsky et al., “Use of low molecular weight heparin in pregnant women with mechanical heart valves,” American Journal of Cardiology, vol. 104, no. 9, pp. 1259–1263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Mazibuko, H. Ramnarain, and J. Moodley, “An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa : a five-year experience,” Cardiovascular Journal of Africa, vol. 23, no. 4, pp. 216–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Cotrufo, M. De Feo, L. S. De Santo et al., “Risk of warfarin during pregnancy with mechanical valve prostheses,” Obstetrics & Gynecology, vol. 99, no. 1, pp. 35–40, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. I. M. van Hagen, J. W. Roos-Hesselink, T. P.E. Ruys et al., “Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac disease (ROPAC),” Circulation, vol. 132, no. 2, pp. 132–142, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. J. S. Ginsberg, W. S. Chan, S. M. Bates, and S. Kaatz, “Anticoagulation of pregnant women with mechanical heart valves,” Archives of Internal Medicine, vol. 163, no. 6, pp. 694–698, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. S. S. Meschengieser, C. G. Fondevila, M. T. Santarelli, and M. A. Lazzari, “Anticoagulation in pregnant women with mechanical heart valve prostheses,” Heart, vol. 82, no. 1, pp. 23–26, 1999. View at Publisher · View at Google Scholar
  18. C. McLintock, L. M. E. McCowan, and R. A. North, “Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 116, no. 12, pp. 1585–1592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. U. Elkayam and S. Goland, “The search for a safe and effective anticoagulation regimen in pregnant women with mechanical prosthetic heart valves,” Journal of the American College of Cardiology, vol. 59, no. 12, pp. 1116–1118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Quinn, K. Von Klemperer, R. Brooks, D. Peebles, F. Walker, and H. Cohen, “Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy : a single-center experience,” Haematologica, vol. 94, no. 11, pp. 1608–1612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. L. A. Barbour, J. L. Oja, and L. K. Schultz, “A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation,” American Journal of Obstetrics and Gynecology, vol. 191, no. 3, pp. 1024–1029, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Friedrich and A. B. Hameed, “Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy,” Journal of Perinatology, vol. 30, no. 4, pp. 253–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Nishimura, C. M. Otto, R. O. Bonow et al., “2014 AHA/ACC guideline for the management of patients with valvular heart disease a report of the American College of Cardiology/American Heart Association task force on practice guidelines,” Circulation, vol. 63, no. 23, pp. 2440–2492, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Shazly and A. Afifi, “RE-ALIGN: first trial of novel oral anticoagulant in patients with mechanical heart valves–the search continues,” Global Cardiology Science and Practice, vol. 2014, no. 1, pp. 88-89, 2014. View at Publisher · View at Google Scholar
  25. C. B. Granger, J. W. Eikelboom, S. J. Connolly et al., “Dabigatran versus warfarin in patients with mechanical heart valves,” New England Journal of Medicine, vol. 369, no. 13, pp. 1206–1214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. I. Weitz, “Expanding use of new oral anticoagulants,” F1000Prime Reports, vol. 6, p. 93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. P. G. Pieper, A. Balci, and A. P. Van Dijk, “Pregnancy in women with prosthetic heart valves,” Netherlands Heart Journal, vol. 16, no. 12, pp. 406–411, 2008. View at Publisher · View at Google Scholar